Alpheus Bingham

Alpheus Bingham is a pioneer in the field of open innovation

and an advocate of collaborative approaches to research and development.

He is co-founder and former president and chief executive

officer of InnoCentive.

Alpheus spent more than 25 years with Eli Lilly and Company; he

retired as vice president of e.Lilly and vice president of Research

Strategy. He had formerly been the vice president of Sourcing Innovation.

He served on both the R&D Policy Committee and the corporate

Operations Committee. He has deep experience in pharmaceutical

research and development, research acquisitions and collaborations,

and R&D strategic planning. During his career, he was instrumental in

creating and developing Lilly’s portfolio management process and

establishing the divisions of Research Acquisitions, the Office of

Alliance Management, and e.Lilly, a business innovation unit, from

which was launched various other ventures that create the advantages

of open and networked organizational structures, including InnoCentive,

YourEncore, Inc., Coalesix, Inc., Maaguzi, Inc., Indigo Biosystems,

Seriosity, Chorus, and Collaborative Drug Discovery, Inc.

He currently serves on the Board of Directors of InnoCentive

and Collaborative Drug Discovery, Inc.; the advisory boards of the

Center for Collective Intelligence at MIT and the Business Innovation

Factory, and as a member of the board of trustees of the Bankinter

Foundation for Innovation in Madrid.

He has lectured extensively at both national and international

events and serves as a Visiting Scholar at the National Center for

Supercomputing Application at the University of Illinois at

Champaign-Urbana. He is also the former chairman of the Board of

Editors of the Research Technology Management Journal.

Alpheus was the recipient of The Economist’s Fourth Annual Innovation

Summit “Business Process Award” for InnoCentive. He was also

named as one of Project Management Institute’s “Power 50” leaders

in October 2005.

Alpheus received a B.S. degree in chemistry from Brigham

Young University and a Ph.D. degree in organic chemistry from Stanford

University.